DocGo Shares Tumble After Earnings Miss and Wider Loss Forecast
DocGo (DCGO) shares fell 12.7% pre-market Tuesday after Q2 2026 earnings missed estimates, with a $0.16 loss per share vs. expected $0.10. Revenue was $73.4M, down 8.7% YoY, and the company widened its full-year adjusted EBITDA loss forecast to $17M-$22M. The decline followed the end of migrant-related contracts, though core revenue grew 19%. The stock trades near its 52-week low of $0.451.
How this was made
The 30-second read
Why it matters
The earnings miss and widened loss guidance suggest a longer path to profitability, pressuring the stock.
Market read
Earnings surprise and guidance downgrade are primary drivers of a sharp pre‑market decline in a micro‑cap stock.
What to watch
Core revenue grew 19% excluding migrant contracts, indicating underlying business strength.
Background
DocGo is a Nasdaq‑listed micro‑cap providing medical transportation services, recently losing migrant‑related contracts.
Ticker impact
DocGo reported Q2 loss wider than expected and widened full-year EBITDA loss guidance, causing a 12.7% pre‑market drop.
downward pressure likely to continue intraday
The surprise loss per share and expanded loss range are new, material information for a micro‑cap, and the stock already fell sharply in pre‑market trading.
Market effects
Highlights volatility risk in the mobile healthcare transport niche.
Limited to U.S. micro‑cap investors; broader market downtrend adds pressure.
Minimal beyond niche investors.
Counterpoint
If the integration of Hicuity Health accelerates revenue growth, the stock could rebound despite short‑term pain.
Key entities
- CompanyDocGo
Mobile healthcare and medical transportation provider.
- CompanyHicuity Health
Telemedicine provider being acquired by DocGo.
